Morgan Stanley MS Co-President Andy Saperstein has been diagnosed with cancer but plans to keep working while receiving treatment, a spokesperson from Morgan Stanley confirmed on Tuesday. Saperstein, 56, said he’s young and otherwise in good health and is starting treatment, so he can put the illness behind him and continue at the firm, according to an internal memo initially reported by Bloomberg and confirmed by the company. Earlier this week, Saperstein named Jed Finn as head of wealth management. Saperstein is co-president of the firm as one of three senior executives that had been considered to take over from retiring…
Master your money.
Subscribe to MarketWatch.
Get this article and all of MarketWatch.
Access from any device. Anywhere. Anytime.
Already a subscriber?
Log In
